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We report a family with two siblings having features of infantile neuroaxonal dystrophy (INAD), with first
degree consanguineous parents. Rapid progressive loss of developing milestones (started from
18 months) and early infantile death of both siblings occurred. Brain magnetic resonance imaging
(MRI) revealed severe rapidly progressive cerebellar atrophy initially reported as early as 18 months,
with the younger brother suffered generalized tonic clonic seizures.
Next generation sequencing revealed a new mutation in PLA2G6 gene (c.319 del C, p. Leu107 Cyst),
resulting in a premature stop codon with shift in the reading frame of resulting protein.
Conclusion: Early onset loss of developmental milestones with cerebellar atrophy and other described
clinical findings ultimately warrant PLA2G6 gene sequencing. Here we report c.319 del. C of PLA2G6
detected by next generation sequencing to be responsible for severe early infantile neuroaxonal dystro-
phy with early infantile death. We conclude that various PLA2G6 gene sites sequencing need further
investigation in INAD in line with clinical correlation. Also INAD seems to be an unrecognized disorder
that needs more categorization for proper diagnosis and genetic counselling.
 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Background
Neurodegeneration associated with PLA2G6 mutations (PLAN)
constitutes a broad spectrum of clinical entities which encom-
passes infantile neuroaxonal dystrophy (INAD1/NBIA2A, MIM #
256600), atypical neuroaxonal dystrophy (NAD), idiopathic neu-
rodegeneration with brain iron accumulation including Karak syn-
drome (NBIA2B, # MIM 610217) and Dystonia Parkinsonism
Complex (PPC).2–8
Infantile neuroaxonal dystrophy (INAD), is a severe progressive
disorder with infantile onset, affecting the motor and cognitive sta-
tus. Brain iron accumulation occurs in a subset of INAD patients,
which represents the distinctive feature of the idiopathic neurode-
generation with brain iron accumulation, NBIA.1 NBIA is a group of
rare, genetic neurological disorders characterized by abnormal
accumulation of iron in the basal ganglia. Ten established genes,
with their causative mutations, are recognized as causatives for
sub types of NBIA, with Pantothenate-Kinase associated neurode-
generation (PKAN) being a well known category.9 Most NBIA syn-dromes have a classic Mendelian inheritance (mostly autosomal
Recessive type).
The globus pallidus is the mostly affected by iron deposition
and the main symptoms include dystonia, choreoathetosis, legs
spacticity, symptoms of parkinsonism and sometimes retinal and
optic nerve degeneration. Psychiatric symptoms and cognitive
decline are predominant features with cerebellar atrophy being a
major finding in MRI in some types of NBIA.
The other disorder INAD is also known as Seitelberger’s disease
or neurodegeneration with brain iron accumulation 2A (NBIA2A).
Presence of axonal spheroids throughout the central and periph-
eral nervous systems is a common feature of this group of psy-
chomotor disorders. A predominant causative gene, PLA2G6,
encoding iPLA2-VIA, a calcium-independent phospholipase is con-
sidered the main molecular background.
Suggestions assume that mutations leading to a complete
absence of the protein are associated with a severe INAD, while
compound heterozygous mutations with a residual protein activity
are associated with the less severe NBIA phenotype. INAD caused
by mutations in PLA2G6 gene manifests typically between ages
6 months and 3 years with rapid progression of truncal hypotonia,
progressive psychomotor delay, cerebellar ataxia, symmetric
pyramidal tract signs, tetraparesis, with lost walking ability or
Fig. 2. Electron microscopic examination of gingival biopsy from the older sister
showing many curvilinear structures, spheroid bodies and filamentous or mem-
branous deposits.
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mus and optic atrophy are also common features.
Atypical NAD has a later onset than INAD (about 4 years of age).
Gait instability, delayed speech, progressive dystonia, dysarthria,
optic atrophy, tetraparesis (spastic or areflexic), and neurobehav-
ioral disturbances are the commonmanifestations. Cerebellar atro-
phy is evident at 2–3 years of age but later brain iron deposition in
the brain becomes evident.5 Karak syndrome was described in ado-
lescents, with manifestations started at 6 years of age, with pro-
gressive ataxia, cognitive decline, ending in lost ambulation by
around 10 years. MRI shows moderate cerebellar atrophy, accumu-
lation of iron in the substantia nigra, and central hyperintensity in
the medial globus pallidus (the eye of-the-tiger-sign).2
From the histopathological point of view, INAD patients show
axonal spheroids in the brain, spinal cord and in the peripheral
nervous system.10
PLA2G6 has a pivotal role in membrane phospholipid metabo-
lism in various cell types through a calcium-independent PLA2
enzyme.11 The biological role of PLA2-VIA enzyme is linked to its
glycine-rich nucleotide binding motif, a lipase motif (GTSTG) and
a calmodulin binding site at the C-terminus.1 The N-terminus
domain has seven ankyrin-like repeats involved in enzymes
oligomerization, and hence full enzymatic activity.11
Deficiency of PLA2- VIA enzyme activity alters the phospholipid
composition of cellular and subcellular membranes, improper
repair of oxidative damage with changes of membrane permeabil-
ity, fluidity and ion homeostasis. The ultimate result would be
apoptosis and cell damage.12
Cases description
Here we present a family presented to us at Clinic of children
with Special Needs, National Research Centre, Cairo, Egypt, with
2 affected siblings. Parents are first degree cousins with no history
of previous abortions (Fig 1).
The older sister was born after a normal course pregnancy, no
prenatal medications, except for routine pregnancy multivitamins.
Normal pregnancy scans with average frequency and strength of
fetal movements were reported. She was born by normal vaginal
delivery in a private clinic, with 3.3 kg birth weight, length of
50 cm and normal head circumference. Serial body measurements
till 2 years age for routine baby check showed normal figures.
She developed head support by 7 months, normal teething, and
supported walking by one year age with taking few steps.
Onset of symptoms developed by 1 6/12 year with gradual pro-
gressive loss of developed milestones in a reversed order of their
development. Mother noticed balance problems started first in sit-
ting, then impaired balanced standing and walking were noticed.
Central body tone and head support were markedly affected with
the later being lost by 2 years and 6 months. By 3 years of age,Fig. 1. Pedigree of studied family showing 1st degshe had limited movements of limbs and body and she was bed
ridden. No history of convulsions or abnormal movements was
reported. Mother described a normal cognitive skills for age till
age of 1 year and 6 months.
Nerve conduction study was done at 21 months age, which did
not reveal abnormalities. Gingival biopsy examination by electron
microscopy at 30 months age showed many curvilinear structures,
spheroid bodies and filamentous or membranous deposits. The his-
tocystes fibroblasts and endothelial cells show scattered spheroid
bodies and few curvilinear structures (Fig 2).
Brain MRI showed cerebellar cortical atrophy with involvement
of vermis and hemisphere, cerebellar cortex hyperintensity on T2-
weighted images is evident. No brain iron accumulation was seen
(Fig 3).ree consanguinity and affected two siblings.
Fig. 3. T2-weighted images of older sister at 2 years age showing: A) minimal cerebral cortical atrophy with hyperintensity on T2-weighted images. B) Cerebellar cortex
hyperintensity with cerebellar cortical atrophy with involvement of vermis and hemisphere.
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prenatal complications were reported and normal foetal move-
ments and pregnancy scans. He was born by normal vaginal deliv-
ery. He acquired appropriate motor and cognitive milestones for
age till 18 months age. He developed head support by 7 months,
and supported standing by 9 months. He did not achieve the fully
balanced unsupported walking status. Onset of symptoms started
at 18 months with regression of developed motor milestones and
balance disturbance. No clear history of seizures or other abnormal
movements was given.
Examination at 3 years age, showed moderate to severe failure
to thrive and, muscle wasting. Motor power was difficult to exam-ine in the presence of severe cognitive decline, pyramidal and cere-
bellar signs. Although precise determination of motor power was
difficult to examine, overall power was evaluated as grade II.
Hypotonia was seen in lower limbs, upper limbs and truncal
muscles, then gradual spacticity developed being firstly seen in
lower limbs. This was associated with decreased deep reflexes with
Babiniski sign being equivocal. At 3 years and 6 months, his height
was on 1.5 SD, head circumference was on 1.8 SD, while weight
was on 2.5 SD.
Eye exam showed continuous horizontal bilateral nystagmus,
strabismus (squint) and optic atrophy. Corticospinal tracts affec-
tion is manifested by loss of voluntary movements and spastic
174 O. Gebril et al. / Egyptian Pediatric Association Gazette 64 (2016) 171–176quadriplegia. Apart from optic atrophy and difficult swallowing,
evaluation of rest of cranial nerves was difficult to perform. Heart
and lungs were normal. No genital anomalies were detected.
Metabolic screening including various organic acids levels was
normal. Electroencephalogram showed bifrontal epileptogenic dis-
charge. BrainMRI done at age of 18 monthswas normal, while cere-
bellar atrophic changes were detected at 2 years age (Fig 4). EEG at
2 years age showed bifrontal epileptogenic discharge (Fig 5).
Molecular analysis
After obtaining written informed consent, we purified DNA
from blood of all affected individuals and the available healthy rel-Fig. 4. T2-weighted brain MRI images of younger brother at 2 years age: A) Mild ceatives. DNA of the affected brother was enriched, using the SureS-
elect Human All Exon Kit version 5 (Agilent),13 and sequenced
using 100-bp paired-end reads on a HiSeq2500 platform (Illumina).
Analysis, base calling, and variant annotation were performed
according to standard methods. Only variants with coverage of
5 or more were analyzed. After excluding common variants
(P1% minor allele frequency represented in the NHLBI exome vari-
ant server, in-house controls or ExAC database), one homozygous
variant remained. We then repeated filtering steps based on differ-
ent in silicon parameters (conservation, pathogenicity prediction,
mutation scoring) and also on combinations of different parame-
ters SIFT, PhyloP,PolyPhen2, LRT, MutationTaster, MutationAsses-
sor, GERP, and CADD,14 and the same candidate variant remainedrebral cortical atrophy with normal basal ganglia, B) Severe cerebellar atrophy.
Fig. 5. EEG of younger brother at 2 years age showing bifrontal epileptogenic discharge.
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(GenBank: NM_001004426.1) in PLA2G6.Discussion
Mutations in PLA2G6 were associated with some forms of INAD
cases.3,6 Although previous studies showed that about only 20% of
INAD patients have PLA2G6 mutations, different types of homozy-
gous or heterozygous mutations leading to overlapping forms of
the disease, with various genotype– phenotype correlations had
been described.5–7 Various mutations in PLAG6 gene were
described in association with the disorder, although the biological
effect on expressed protein would be diverse (see Table 1)
Mutations that lead to a complete absence of the protein are
suspected to cause classical INAD profile, with early onset and
rapid disease progression. Compound heterozygous mutations
with a possible residual protein activity are suspected to be associ-
ated with the less severe NBIA phenotype.
Concerning the other linked category NBIA, increasing data
showed various mutations in PLA2G6 gene to be evident in familiesTable 1
Previously described PLA2G6 gene mutations in infantile neuroaxonal dystrophy cases am
PLA2G6 mutation Clinical data
p.Leu224Pro, p.Asp283Asn, p.Arg329Cys, p.Leu491Phe, and p.
Arg649His)
Cerebellar atrophy a
c671T > C at p. L224P, homozygous Mild cerebellar atrop
G68A, homozygous Common described s
p.Asp283Asn and a unique intragenic deletion of exons 4 and 5 Progressive brain atr
EEG showed diffuse
p.V691del) Cerebellar atrophy a
– c.1524dupC (p.Lys509Glnfs⁄5), p.Arg600Trp
– c.1756G > A (Glycine 568Arg)
– c.2375A > C (His792Pro)
– Deletion/Frameshift Duplication, c.1674delG, Duplication
of exons 4–7
– c.2370T > G (p.Tyr 790), c.691G > C) (p.Gly231Arg)
Cerebellar atrophy, c
– cerebellar atroph
iron in pallidus
– cerebellar atroph
– cerebellar atroph
– cerebellar atroph
iron in basal ganwith NBIA. Four genetic variants were identified by Lu and others;
homozygous c.991G > T (p.Asp331Tyr) mutation, compound
heterozygous c.991G > T/c.1077G > A (p.Met358IlefsX) mutation,
c.1976A > G (p.Asn659Ser) mutation, while an exon 1 hetero-
deletion was associated with young onset Parkinson disease.21
Our patients show classic radiological features of INAD; with
cerebellar cortical atrophy with involvement of vermis and hemi-
sphere, cerebellar cortex hyperintensity on T2-weighted images
being evident as early as 2 years with mild cortical atrophy. Other
features as caudate- and putamen hyperintensity on T2-weighted
imaging was not clear, suggesting in accordance with previous data
that those findings appear later during disease course and would
be absent in severe progressive form.
Cerebral white-matter disease and reduction of the N-acetyl
aspartate was documented in older ages infantes with INAD, our
cases have mild cerebral cortical atrophy with normal blood levels
of N-acetyl aspartate.
Generalized tonic–clonic attacks was found only in the affected
brother among our family, which was also an inconsistent finding
in previously described cases.12,22 Our findings thus indicate that in
the case of classical INAD with severe rapid disease progression,ong various studies.
Reference
nd other described clinical features Kapoor et al., 201615
hy, sensorineural hearing loss Kulkarni et al., 201616
ymptoms, tetraparesis, psychomotor regression Wang et al., 201617
ophy and T2 hypointensity in the globus pallidus,
increase in sharp waves
Yamamoto et al., 201518
nd claval hypertrophy, pallidal iron deposition Romani M et al., 201519
laval hypertrophy, abnormal corpus callosum
y, claval hypertrophy, abnormal corpus callosum,
y, claval hypertrophy, abnormal corpus callosum
y, claval hypertrophy, abnormal corpus callosum
y, claval hypertrophy, abnormal corpus callosum ,
glia
Illingworth et al., 201420
176 O. Gebril et al. / Egyptian Pediatric Association Gazette 64 (2016) 171–176the associated neuroradiological presentation and its progression
pattern may vary. This goes in accordance with similar cases study
that described some uncommon features manifesting much earlier
than expected in disease course.1
Current study is one of few studies that described intragenic
PLA2G6 deletion characterized at the sequence level using next
generation sequencing. Only one large deletion encompassing the
3_ of PLA2G6 and the second intron of the flanking gene was
reported in association with INAD.1,3
Next generation sequencing would provide significant molecu-
lar data in cases with INAD, and provide a definite tool for prenatal
genetic counselling, ultimately improving the quality of life of
affected cases and their families.
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